NextPlat (NASDAQ:NXPL) Releases Earnings Results

by · The Cerbat Gem

NextPlat (NASDAQ:NXPL – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.42) earnings per share for the quarter, Zacks reports. NextPlat had a negative net margin of 21.56% and a negative return on equity of 53.22%. The firm had revenue of $9.86 million during the quarter.

Here are the key takeaways from NextPlat’s conference call:

  • NextPlat said its turnaround is largely complete, with Q1 showing record-level gross margins, lower operating expenses, and a clear path to improving profitability in the second half of 2026.
  • The healthcare segment posted a major improvement, with gross margin rising to 39% from about 20% a year ago and the segment generating positive operating income for the quarter.
  • The company secured five new 340B pharmacy service agreements in the quarter, a record, and expects those customers to begin contributing to revenue in the third quarter after onboarding.
  • Management highlighted new growth initiatives, including a nationwide fulfillment partnership and a planned e-commerce healthcare site that will sell prescription drugs, GLP-1 products, and OTC items, expected to launch before the end of Q2.
  • Quarterly revenue declined year over year to about $10 million, though the company said the mix is shifting toward higher-margin contract and fulfillment revenue, while e-commerce remained steady at about $3.2 million.

NextPlat Price Performance

NXPL stock traded up $0.42 during mid-day trading on Friday, reaching $6.68. 1,288 shares of the company’s stock were exchanged, compared to its average volume of 94,457. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.65 and a quick ratio of 2.27. The company has a market cap of $18.10 million, a price-to-earnings ratio of -1.52 and a beta of 1.91. The stock’s 50 day moving average is $5.42 and its 200 day moving average is $6.07. NextPlat has a 12-month low of $3.38 and a 12-month high of $11.10.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC purchased a new position in NextPlat Corp. (NASDAQ:NXPL – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat at the end of the most recent reporting period. Institutional investors own 1.30% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings raised NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Get Our Latest Analysis on NextPlat

About NextPlat

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.

Read More